top of page

Price

chg

chg neg

quotes and stock data may be delayed 15 minutes

 My Notes

Only BPIQ Pro members can create company notes. Learn more here.

52 wk low

low api

52 wk hi

high api

Cash

$120.7M

Burn Rate (Qtr)

$16.8 M

Mkt Cap

mkt cap api

Avg Volume

volume api

*cash/burn updated:

Q1 '22

Drug Pipeline

Click the button to see the updated pipeline

No drug found

We don't have any drug data for this company yet

Drug | Disease (links)

Stage (next event)

Catalyst Date

Drug Name

Indication

Phase

Event

Exp Date

A free account is required to see the catalyst dates, notes, and more!

Create Free Account Now

Loading Catalysts...

search in progress

Pipeline powered by

CRIS

BPIQ_Logo_RGB-01.jpg

Company Profile

We are a biotechnology company focused on the development of first-in-class and innovative therapeutics for the treatment of cancer.

Recent Posts

See what the community is saying - click to see full post.

EHA 2022 (European Hematology Association) - Annual Meeting

ASCO 2022 Annual Meeting (American Society of Clinical Oncology) - Clinical Trial Presentations

January 2022 Big-Mover™ Stocks and Movers to Watch Report

Q2 Corporate Quarterly Updates: Small and Mid-Cap Biotech Companies to Watch

NTLA Shows Efficacy for In Vivo Gene Editing

EHA2021 Investor Hub

bottom of page